1-苄基-4-哌啶酮-3-羧酸乙酯 | 41276-30-6

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 1-苄基-4-哌啶酮-3-羧酸乙酯
• 中文别名: 1-苄基-3-乙氧羰-4-哌啶酮；乙基1-苄基-4-羰基-3-哌啶羧酸酯
• 英文名称: ethyl 1-benzyl-4-oxopiperidine-3-carboxylate
• CAS: 41276-30-6
• 化学式: C₁₅H₁₉NO₃
• mdl: MFCD00792540
• 分子量: 261.321
• InChiKey: ROSZJQBQGFBFSW-UHFFFAOYSA-N

物化性质

• 沸点：
  379.7±42.0 °C(Predicted)
• 密度：
  1.154±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.466
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P233,P260,P261,P264,P270,P271,P280,P301+P312,P302+P352,P304,P304+P340,P305+P351+P338,P312,P321,P330,P332+P313,P337+P313,P340,P362,P403,P403+P233,P405,P501
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  | 室温 |

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Benzyl-3-ethoxycarbonyl-4-piperidone
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Benzyl-3-ethoxycarbonyl-4-piperidone
CAS number: 41276-30-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C15H19NO3
Molecular weight: 261.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-苄基-4-哌啶酮-3-羧酸乙酯 在 盐酸 作用下， 以 水 为溶剂， 生成 N-苄基哌啶酮
  参考文献：
  名称：

  新型抗菌剂1β-甲基碳青霉烯衍生物的合成及体外活性

  摘要：

  描述了具有吡咯烷和哌啶部分的新系列 1β-甲基碳青霉烯的合成。测试了它们对革兰氏阳性菌和革兰氏阴性菌的体外抗菌活性，并研究了取代基对吡咯烷环的影响。具有肟-吡咯烷部分的特定化合物 III b 显示出最有效的抗菌活性。

  DOI：

  10.1002/ardp.200800014
• 作为产物：
  描述：

  3-[苄基-(2-乙氧基羰基乙基)-氨基]-丙酸乙酯 在 sodium ethanolate 作用下， 以 5,5-dimethyl-1,3-cyclohexadiene 为溶剂， 反应 5.0h， 生成 1-苄基-4-哌啶酮-3-羧酸乙酯
  参考文献：
  名称：

  环亚芳基酮的合成及其抗增殖活性：单亚苄基和二亚苄基衍生物的直接比较

  摘要：

  摘要为了进一步了解烯酮和二烯酮的结构修饰对其抗增殖性能的影响，共有25种烯酮衍生物：（E）-2-亚苄基-1-环己酮，（E）-2-亚苄基-1-四酮，（E）-2-亚苄基-1-茚满酮和二烯酮：（E，E）-2,5-或2,6-二亚苄基-1-环酮，（E，E）-3,5-二亚苄基-4-哌啶酮是使用新开发的“一锅法”合成方法合成的。由于它们均在亚芳基部分具有相同的芳基取代基（苯基或4-氯苯基），因此可以比较单点结构修饰（环或N取代的类型）对其IC 50的效能价值观。针对以下四种人类粘附癌细胞系评估了它们的抗增殖活性：HeLa，A431，A2780和MCF7。细胞毒性筛选显示，在这方面，二亚苄基二烯酮通常占单亚苄基烯酮的主导。与它们的同环二烯酮类似物相比，含氮杂环二烯酮同时对这些人类癌细胞系表现出更高的抑制特性。八种新制备的4-哌啶酮衍生物之一N-（γ-氧代丁基）-（E，E）-3,5-双（对氯苄叉基）-4-哌啶酮是有效的细胞生长抑制剂（IC

  DOI：

  10.1007/s00706-015-1426-7

文献信息

• Construction of Functionalized Carbocycles Having Contiguous Tertiary Carbinol and All-Carbon Stereogenic Centers
  作者：Chennakesava Reddy、Srinivasarao Arulananda Babu、Nayyar Ahmad Aslam、Vadla Rajkumar

  DOI：10.1002/ejoc.201201382

  日期：2013.4

  A highly stereoselective protocol is reported for customizing functionalized carbocyclic building blocks (β-hydroxy esters) and bicyclic lactones with a stereoarray that contains contiguous tertiary carbinol and all-carbon stereocenters. The efficient asymmetric induction and diastereofacial selective addition of allyl and propargyl indiums to hindered α,α-disubstituted cycloalkanones is presented

  报告了一种高度立体选择性的协议，用于定制功能化碳环结构单元（β-羟基酯）和双环内酯，其立体阵列包含连续的叔甲醇和全碳立体中心。介绍了烯丙基和炔丙基铟与受阻 α,α-二取代环烷酮的有效不对称诱导和非对映选择性加成。代表性产物的立体化学是从单晶 X 射线晶体结构分析中明确建立的，并提出了一种合理的反应途径来支持高非对映面选择性。
• [EN] PIPERIDINYLHYDROXYETHYLPIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTORS<br/>[FR] PIPÉRIDINYLHYDROXYÉTHYLPIPÉRIDINES UTILISABLES EN TANT QUE MODULATEURS DES RÉCEPTEURS AUX CHIMIOKINES
  申请人：GLAXO GROUP LTD

  公开号：WO2009049113A1

  公开（公告）日：2009-04-16

  The present invention relates to a compound of the formula (I), or a pharmaceutically acceptable salt thereof, wherein R1-R8 and X, m, and n are defined. Compounds and compositions of the present invention are useful the treatment of atherosclerosis.

  本发明涉及公式（I）的化合物或其药学上可接受的盐，其中R1-R8和X、m和n已定义。本发明的化合物和组合物对动脉粥样硬化的治疗是有用的。
• CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF
  申请人：FLX Bio, Inc.

  公开号：US20180072743A1

  公开（公告）日：2018-03-15

  Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of chemokine receptor activity.

  披露的内容包括但不限于，用于调节趋化因子受体活性的化合物及其使用方法。
• New P2X3 receptor antagonists. Part 2: Identification and SAR of quinazolinones
  作者：Gábor Szántó、Attila Makó、István Vágó、Tamás Hergert、Imre Bata、Bence Farkas、Sándor Kolok、Mónika Vastag

  DOI：10.1016/j.bmcl.2016.07.013

  日期：2016.8

  Numerous potent P2X3 antagonists have been discovered and the therapeutic potential of P2X3 antagonism already comprises proof-of-concept data obtained in clinical trials with the most advanced compound. We have lately reported the discovery and optimization of thia-triaza-tricycle compounds with potent P2X3 antagonistic properties. This Letter describes the SAR of a back-up series containing a 4-oxo-quinazoline

  已经发现了许多有效的P2X3拮抗剂，P2X3拮抗作用的治疗潜力已经包括在最先进的化合物的临床试验中获得的概念验证数据。我们最近报道了具有有效P2X3拮抗特性的硫代-三氮杂-三环化合物的发现和优化。这封信描述了一个含有4-氧-喹唑啉中心环的备用序列的SAR。提出了高效化合物51的发现。
• [EN] GLYCOSIDASE INHIBITORS<br/>[FR] INHIBITEURS DE GLYCOSIDASES
  申请人：ASCENEURON S A

  公开号：WO2017144633A1

  公开（公告）日：2017-08-31

  Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

  式(I)中A、R、W、Q、n和m的含义如权利要求书所述，可用于治疗tau病和阿尔茨海默病。